S2M Stock Overview
Develops, produces, and sells wound healing products for burns and chronic wounds in Sweden.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
S2Medical AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.049 |
52 Week High | kr0.67 |
52 Week Low | kr0.018 |
Beta | 0.91 |
1 Month Change | -37.42% |
3 Month Change | -42.35% |
1 Year Change | -78.60% |
3 Year Change | -99.28% |
5 Year Change | -99.75% |
Change since IPO | -99.74% |
Recent News & Updates
Recent updates
Shareholder Returns
S2M | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 7.0% | -4.4% | 0.6% |
1Y | -78.6% | -9.4% | 16.0% |
Return vs Industry: S2M underperformed the Swedish Medical Equipment industry which returned -9.4% over the past year.
Return vs Market: S2M underperformed the Swedish Market which returned 16% over the past year.
Price Volatility
S2M volatility | |
---|---|
S2M Average Weekly Movement | 19.3% |
Medical Equipment Industry Average Movement | 6.7% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 13.2% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: S2M's share price has been volatile over the past 3 months.
Volatility Over Time: S2M's weekly volatility has decreased from 35% to 19% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 20 | Petter Sivlér | www.s2m.se |
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover.
S2Medical AB (publ) Fundamentals Summary
S2M fundamental statistics | |
---|---|
Market cap | kr13.50m |
Earnings (TTM) | -kr17.12m |
Revenue (TTM) | kr11.87m |
1.1x
P/S Ratio-0.8x
P/E RatioIs S2M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
S2M income statement (TTM) | |
---|---|
Revenue | kr11.87m |
Cost of Revenue | kr2.48m |
Gross Profit | kr9.39m |
Other Expenses | kr26.51m |
Earnings | -kr17.12m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.062 |
Gross Margin | 79.13% |
Net Profit Margin | -144.31% |
Debt/Equity Ratio | 0% |
How did S2M perform over the long term?
See historical performance and comparison